Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 2, 2026

Mechanical Stimulation of Chondrocyte-agarose Hydrogels
12:45

Mechanical Stimulation of Chondrocyte-agarose Hydrogels

Published on: October 27, 2012

12.1K

Catering to chondrocytes.

Christopher H Evans1

  • 1Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN 55905, USA. evans.christopher@mayo.edu.

Science Translational Medicine
|November 30, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-Articular Purified Exosome Product and Hyaluronan Attenuate Osteoarthritis Progression in a Minimally Invasive Turkey Model.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2026
Same author

Osteoarthritis Gene Therapy: A 30-Year Journey From Concept to Clinical Trials.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2026
Same author

Lyophilization of Adeno-Associated Virus Serotypes for Storage and Global Distribution.

Biomedicines·2026
Same author

More arthritis gene therapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Osteoarthritis gene therapy: Expanding the scope of genetic therapies.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Gene therapy pipelines for osteoarthritis: current innovations, operational challenges, and future directions.

Connective tissue research·2025
Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026
Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026
Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026
Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026
Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026
See all related articles

A novel drug delivery method targets chondrocytes directly within cartilage, offering a promising new approach for treating osteoarthritis. This strategy aims to improve therapeutic efficacy for joint degeneration.

Area of Science:

  • Biomedical Engineering
  • Cartilage Biology
  • Drug Delivery Systems

Background:

  • Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown.
  • Current OA treatments often lack targeted delivery to chondrocytes, leading to suboptimal efficacy and potential side effects.
  • Chondrocytes are critical cells within cartilage responsible for maintaining its structure and function.

Purpose of the Study:

  • To develop and evaluate an innovative in situ drug delivery strategy targeting chondrocytes.
  • To explore new therapeutic avenues for osteoarthritis treatment.
  • To improve the localized delivery of therapeutic agents within the joint.

Main Methods:

  • Development of a novel drug delivery system designed for chondrocyte targeting.

More Related Videos

A Microfluidic Platform for Stimulating Chondrocytes with Dynamic Compression
07:23

A Microfluidic Platform for Stimulating Chondrocytes with Dynamic Compression

Published on: September 13, 2019

7.1K
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
09:58

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

21.3K

Related Experiment Videos

Last Updated: Feb 2, 2026

Mechanical Stimulation of Chondrocyte-agarose Hydrogels
12:45

Mechanical Stimulation of Chondrocyte-agarose Hydrogels

Published on: October 27, 2012

12.1K
A Microfluidic Platform for Stimulating Chondrocytes with Dynamic Compression
07:23

A Microfluidic Platform for Stimulating Chondrocytes with Dynamic Compression

Published on: September 13, 2019

7.1K
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
09:58

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

21.3K
  • In situ application and evaluation of the delivery system within a relevant biological model.
  • Assessment of drug uptake and distribution within chondrocytes.

    • Main Results:

    • The developed strategy successfully delivered drugs to chondrocytes in situ.
    • Demonstrated potential for enhanced therapeutic agent concentration at the target site.
    • Indicated a new pathway for localized treatment of cartilage degeneration.

    Conclusions:

    • An innovative in situ drug delivery strategy for chondrocytes has been established.
    • This approach presents a promising new avenue for osteoarthritis treatment.
    • Further research may validate this method for clinical applications in joint diseases.